" class="no-js "lang="en-US"> Jim Datin - Medtech Alert
Saturday, October 18, 2025
Jim Datin

Jim Datin

About Jim Datin

I am a seasoned executive with significant experience in the Pharmaceutical, Life Sciences and Biotech industries. Over the course of my career, I have been a successful CEO, director, and executive in companies throughout the United States, Europe, and Asia. I have also completed more than 40 transactions including venture investments, buyouts, acquisitions, mergers, IPOs, licensing and partnership agreements.

In my current role as President and CEO of BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, I am committed to driving industry leading customer satisfaction and supporting our staff of industry experts in the innovative work they do for our clients in the pharmaceutical and biotech industries.

During my time with the company, we have been recognized by the Inc. 5000 list of Fastest Growing Companies in 2013, 2014, 2016, 2017, 2018, 2019 & 2020. We also boast award-winning customer service and have one of the highest employee retention rates in the industry.

Related Story

BioAgilytix to Purchase Australia-Based 360biolabs®

August 16 2021

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical […]